DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ rallied 2.69% to $1.91 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.89% to 19,338.29 and Dow Jones Industrial Average falling 0.16% to 43,153.13.
The stock's rise snapped a five-day losing streak.
Inovio Pharmaceuticals Inc. closed 87.05% below its 52-week high of $14.75, which the company reached on April 1st.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.93% to $147.77, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 1.03% to $26.49.
Trading volume (489,103) remained 551,690 below its 50-day average volume of 1.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 16, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 16, 2025 17:28 ET (22:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。